Reglan Tied to Serious Movement Disorder

Reglan is a drug approved by the FDA to treat short-term gastrointestinal disorders. I emphasize short-term because long-term use of Reglan has now been linked to a serious, permanent movement disorder known as tardive dyskinesia. Tardive dyskinesia is a permanent disorder that causes involuntary and repetitive muscle movements. There is no known cure. The approved length of time a patient should use Reglan is no more than 90 days. Chances of contracting tardive dyskinesia dramatically increase the longer a patient uses the drug past the 90 day window. The disorder is characterized by:
Tardive dyskinesia is characterized by:
• Involuntary/ repetitive movements of the extremities
• Facial tics
• Lip smacking, pursing and puckering
• Face Grimacing
• Tongue protrusion
• Rapid eye movements or blinking
• Impaired movement of the fingers.
• Restless Leg Syndrome (RLS)
Reglan lawsuits allege that Wyeth, the manufacturer of Reglan, encouraged doctors to prescribe the drug for longer than the approved period. These cases are another instance in which a drug’s marketing campaign leads to serious consumer injuries.